Oh, Jiwon http://orcid.org/0000-0001-5519-6088
Arbour, Nathalie
Giuliani, Fabrizio
Guenette, Melanie
Kolind, Shannon
Lynd, Larry
Marrie, Ruth Ann
Metz, Luanne M.
Patten, Scott B.
Prat, Alexandre
Schabas, Alice
Smyth, Penelope
Tam, Roger
Traboulsee, Anthony
Yong, V. Wee
Funding for this research was provided by:
Brain Canada
Multiple Sclerosis Society of Canada
Biogen Canada
Hoffman-La Roche Limited
Government of Alberta
Article History
Received: 31 May 2021
Accepted: 13 October 2021
First Online: 27 October 2021
Declarations
:
: All participating sites obtained local research ethics board approval prior to study initiation.• Providence St. Joseph’s and St. Michael’s Hospital Healthcare Research Ethics Board, St. Michael’s Hospital (18–325).• Conjoint Health Research Ethics Board, University of Calgary (18–1853).• Health Research Ethics Board, University of Alberta (Pro00086907).• Clinical Research Ethics Board, University of British Columbia (H18–03047).• Comité d’éthique de la recherche du Centre hospitalier de l’Université de Montréal (18–293).Participants must speak and understand English or French to a reasonable degree and be able to independently provide written informed consent to participate in the study. Study related activities are not performed before completion of the informed consent document. Each participating site and funding body has executed required contracts and agreements outlining data access, storage and transfer.All CanProCo participants provided written informed consent.
: All participants have provided consent to publish their de-identified and aggregated data.
: Jiwon Oh has received research funding from Biogen-Idec and Roche, and personal fees for consulting for Biogen-Idec and Roche.Nathalie Arbour reports no competing interests.Fabrizio Giuliani has received honoraria from Biogen, Novartis, Roche for industry-sponsored talks, and consulting fees from Biogen and Novartis. He is the recipient of research grants from Biogen and Roche.Melanie Guenette reports no competing interests.Shannon Kolind has received research funding from Roche.Larry Lynd reports no competing interests.Ruth Ann Marrie reports no competing interests.Luanne M. Metz reports no competing interests.Scott B. Patten reports no competing interests.Alexandre Prat has received research support from Biogen and Roche; has received consulting fees from Biogen-Idec and Roche.Alice Schabas has received personal fees for consulting for Biogen-Idec and Roche.Penny Smyth has received unrestricted research support from Biogen-Idec; and has received consulting fees and honoraria for speaking activities from Biogen-Idec and Roche.Roger Tam holds a grant from the Praxis Spinal Cord Institute for an unrelated educational program.Anthony Traboulsee has received research support from Sanofi Genzyme and Roche; has received consulting fees from Sanofi Genzyme, Roche, Teva Neuroscience, Novartis, Biogen and EMD Serono; and has received honoraria for his involvement in speaker bureau activities for Sanofi Genzyme and Roche.V. Wee Yong has received honoraria from Biogen, Novartis, Roche, Sanofi-Genzyme and Teva for industry-sponsored talks, and consulting fees from EMD Serono, Roche and Sanofi-Genzyme. He is the recipient of unrestricted educational grants from Biogen, EMD Serono, Novartis, Roche, Sanofi-Genzyme and Teva to support educational activities of the Alberta MS Network, which he directs.